Literature DB >> 1689898

Assay of FK 506 in plasma.

E M Cadoff1, R Venkataramanan, A Krajack, A S Jain, J J Fung, S Todo, T E Starzl.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 1689898      PMCID： PMC2903895     

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  2 in total

1.  Renal transplantation in baboons under FK 506.

Authors:  S Todo; A Demetris; Y Ueda; O Imventarza; E Cadoff; A Zeevi; T E Starzl
Journal:  Surgery       Date:  1989-08       Impact factor: 3.982

2.  A highly sensitive method to assay FK-506 levels in plasma.

Authors:  K Tamura; M Kobayashi; K Hashimoto; K Kojima; K Nagase; K Iwasaki; T Kaizu; H Tanaka; M Niwa
Journal:  Transplant Proc       Date:  1987-10       Impact factor: 1.066
  2 in total
  16 in total

1.  Intravenous, oral pharmacokinetics, and oral dosing of FK 506 in small bowel transplant patients.

Authors:  A Jain; R Venkataramanan; S Todo; K Abu-Elmagd; J Fung; V Warty; A Tzakis; J Reyes; M Alessiani; T E Starzl
Journal:  Transplant Proc       Date:  1992-06       Impact factor: 1.066

2.  Effect of renal ischemia on plasma levels of FK 506 in rats.

Authors:  M Sakr; G Zetti; J Gavaler; H Farghali; R Venkataramanan; G Carrieri; T Starzl; D Van Thiel
Journal:  Transplant Proc       Date:  1992-02       Impact factor: 1.066

3.  Low-dose of FK 506 and associated blood levels in allotransplantation of rat liver, heart, and skin.

Authors:  X Cai; J Harnaha; P N Rao; J Flowers; R Venkataramanan; V Warty; J J Fung; T E Starzl
Journal:  Transplant Proc       Date:  1992-08       Impact factor: 1.066

Review 4.  FK 506 and autoimmune disease: perspective and prospects.

Authors:  A W Thomson; T E Starzl
Journal:  Autoimmunity       Date:  1992       Impact factor: 2.815

5.  Bioassay of plasma specimens from liver transplant patients on FK 506 immunosuppression.

Authors:  A Zeevi; G Eiras; G Burckart; A Jain; A Kragack; R Venkataramanan; S Todo; J Fung; T E Starzl; R J Duquesnoy
Journal:  Transplant Proc       Date:  1990-02       Impact factor: 1.066

6.  Interaction between FK506 and clotrimazole in a liver transplant recipient.

Authors:  L Mieles; R Venkataramanan; I Yokoyama; V J Warty; T E Starzl
Journal:  Transplantation       Date:  1991-12       Impact factor: 4.939

Review 7.  In vitro assessment of FK 506 immunosuppressive activity in transplant patients.

Authors:  A Zeevi; R Venkataramanan; V Warty; G Eiras; M Woan; K Abu-Elmagd; M Alessiani; A Jain; A J Demetris; T Zerbe
Journal:  Transplant Proc       Date:  1991-12       Impact factor: 1.066

Review 8.  The use of therapeutic drug monitoring to optimise immunosuppressive therapy.

Authors:  S M Tsunoda; F T Aweeka
Journal:  Clin Pharmacokinet       Date:  1996-02       Impact factor: 6.447

9.  Pharmacokinetics of FK506 in liver transplant recipients after continuous intravenous infusion.

Authors:  A B Jain; K Abu-Elmagd; H Abdallah; V Warty; J Fung; S Todo; T E Starzl; R Venkataramanan
Journal:  J Clin Pharmacol       Date:  1993-07       Impact factor: 3.126

Review 10.  Tacrolimus. A review of its pharmacology, and therapeutic potential in hepatic and renal transplantation.

Authors:  D H Peters; A Fitton; G L Plosker; D Faulds
Journal:  Drugs       Date:  1993-10       Impact factor: 9.546
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.